Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Array BioPharma and Genentech patent novel ERK inhibitors

Feb. 21, 2013

CEP-11981 demonstrates activity against urothelial carcinoma in mice

Feb. 21, 2013

Puma reaches SPA agreement for phase III trial in HER2-positive metastatic breast cancer

Feb. 21, 2013

Treatment begins in AEZS-108 study in triple-negative breast cancer

Feb. 21, 2013

Researchers at Gerinda Therapeutics disclose novel protein kinase inhibitors

Feb. 21, 2013

Beta Pharma presents new ALK/c-Met inhibitors

Feb. 21, 2013

Antiproliferative activity demonstrated for palbociclib in RCC cells

Feb. 20, 2013

Merck & Co. presents new inhibitors of mTORC1/2

Feb. 20, 2013

Nippon Kayaku files for additional approval of Hycamtin in Japan

Feb. 20, 2013

Eli Lilly discloses novel notch signaling inhibitors

Feb. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...